公司資料
Acurx Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- ACXP
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.47 USD (+1.38%)
收盤價
最後更新: 2026年8月21日
7.74M USD
市值
股價為何變動
As of Aug 21, 2026, ACXP closed up 1.38% at $1.47. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Acurx Pharmaceuticals is an anti-infective company focused on novel antibiotics for bacterial infections. Its platform is aimed at addressing antibiotic resistance in difficult pathogens.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Acurx sits in specialty biopharma.
商業模式特徵
The company depends on clinical data, anti-infective differentiation, and the commercial opportunity in resistant infections.
生技產業定位
Acurx is a niche anti-infective name whose valuation depends on regulatory and development progress.
未來催化劑
- Acurx’s catalysts are ibezapolstat and the recurrent C. difficile program, along with any regulatory or development step that keeps the oral-antibiotic story moving. The company remains highly dependent on clinical progress.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。